InicioDEVA • IST
add
Deva Holding AS
Cierre anterior
60,45 ₺
Intervalo diario
59,90 ₺ - 61,05 ₺
Intervalo anual
51,00 ₺ - 81,75 ₺
Cap. bursátil
12,18 mil M TRY
Volumen medio
702,18 mil
Relación precio-beneficio
-
Rentabilidad por dividendo
-
Bolsa de valores principal
IST
Noticias sobre los mercados
Datos financieros
Estado de resultados
Ingresos
Ingresos netos
| (TRY) | dic 2025info | Cambio interanual |
|---|---|---|
Ingresos | 5491,08 M | -2,19 % |
Gastos operativos | 1741,14 M | 2,67 % |
Ingresos netos | -1344,04 M | -524,24 % |
Margen de beneficio neto | -24,48 | -537,50 % |
Beneficios por acción | — | — |
EBITDA | 622,26 M | -48,71 % |
Tipo impositivo efectivo | -294,28 % | — |
Balance general
Activos totales
Responsabilidades totales
| (TRY) | dic 2025info | Cambio interanual |
|---|---|---|
Efectivo y a corto plazo | 3592,62 M | 26,49 % |
Activos totales | 37,63 mil M | -3,31 % |
Responsabilidades totales | 11,31 mil M | -3,14 % |
Patrimonio total | 26,32 mil M | — |
Acciones en circulación | 200,02 M | — |
Precio-valor contable | 0,46 | — |
Rentabilidad económica | -0,61 % | — |
Retorno sobre capital | -0,70 % | — |
Flujo de caja
Variación neta del flujo de caja
| (TRY) | dic 2025info | Cambio interanual |
|---|---|---|
Ingresos netos | -1344,04 M | -524,24 % |
Efectivo de operaciones | 1493,32 M | 27,32 % |
Efectivo de inversión | -838,87 M | -130,98 % |
Efectivo de financiación | 260,62 M | 117,90 % |
Variación neta del flujo de caja | 885,62 M | 206,74 % |
Flujo de caja libre | -165,38 M | 95,31 % |
Información sobre la empresa
DEVA Holding A.Ş. is a leading Turkish pharmaceutical company founded in 1958. As of 2024, it ranked 3rd in unit sales and 6th in TL sales in Turkey’s pharmaceutical market.
The company operates three EU GMP- and US FDA-approved facilities in Çerkezköy and Kartepe, with an annual production capacity of 620 million units. DEVA’s portfolio covers 10 therapeutic areas, including cardiovascular, dermatology, ophthalmology, hematology, and anti-infectives, and includes 1,404 registered products across 82 countries.
Recognized as Turkey’s top pharmaceutical company in R&D spending by Turkishtime’s 2024 R&D 250 Report, DEVA employs over 500 researchers and 3,000 staff in total. Guided by sustainability and innovation, the company focuses on developing accessible, effective, and environmentally responsible healthcare solutions for both domestic and global markets. Wikipedia
Fundación
22 sept 1958
Sitio web
Empleados
3.023
